120 related articles for article (PubMed ID: 2706624)
21. Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Markiewicz L; Gurpide E
Methods Find Exp Clin Pharmacol; 1997 May; 19(4):215-22. PubMed ID: 9228646
[TBL] [Abstract][Full Text] [Related]
22. Effects of steroid hormones and antihormones in cultured cells.
Jung-Testas I; Baulieu EE
Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
[TBL] [Abstract][Full Text] [Related]
23. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
[TBL] [Abstract][Full Text] [Related]
24. Effects of transforming growth factors and regulation of their mRNA levels in two human endometrial adenocarcinoma cell lines.
Anzai Y; Gong Y; Holinka CF; Murphy LJ; Murphy LC; Kuramoto H; Gurpide E
J Steroid Biochem Mol Biol; 1992 Jun; 42(5):449-55. PubMed ID: 1616874
[TBL] [Abstract][Full Text] [Related]
25. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
Briand P; Lykkesfeldt AE
Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
[TBL] [Abstract][Full Text] [Related]
26. Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture.
Darbre PD; Curtis S; King RJ
Cancer Res; 1984 Jul; 44(7):2790-3. PubMed ID: 6722808
[TBL] [Abstract][Full Text] [Related]
27. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
[TBL] [Abstract][Full Text] [Related]
28. Comparison of combinatory effects of PCBs (118, 138, 153 and 180) with 17 beta-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells.
Ptak A; Mazur K; Gregoraszczuk EL
Toxicol Ind Health; 2011 May; 27(4):315-21. PubMed ID: 20947654
[TBL] [Abstract][Full Text] [Related]
29. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa).
Holinka CF; Hata H; Kuramoto H; Gurpide E
J Steroid Biochem; 1986 Jan; 24(1):85-9. PubMed ID: 3702430
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
31. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo.
Howe SR; Gottardis MM; Everitt JI; Walker C
Endocrinology; 1995 Nov; 136(11):4996-5003. PubMed ID: 7588234
[TBL] [Abstract][Full Text] [Related]
32. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
33. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells.
Hochner-Celnikier D; Greenfield C; Finci-Yeheskel Z; Milwidsky A; Gutman A; Goldman-Wohl D; Yagel S; Mayer M
Mol Hum Reprod; 1997 Dec; 3(12):1019-27. PubMed ID: 9464846
[TBL] [Abstract][Full Text] [Related]
35. Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants.
Sonnenschein C; Szelei J; Nye TL; Soto AM
Oncol Res; 1994; 6(8):373-81. PubMed ID: 7894086
[TBL] [Abstract][Full Text] [Related]
36. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
Gierthy JF; Lincoln DW; Roth KE; Bowser SS; Bennett JA; Bradley L; Dickerman HW
J Cell Biochem; 1991 Feb; 45(2):177-87. PubMed ID: 2055945
[TBL] [Abstract][Full Text] [Related]
37. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
Karey KP; Sirbasku DA
Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
[TBL] [Abstract][Full Text] [Related]
38. [The effect of estrogen and its receptor antagonist on the growth of human gastric cancer cell line in vitro].
Tan D; Gu Z; Wang H
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):93-6. PubMed ID: 7656814
[TBL] [Abstract][Full Text] [Related]
39. Effect of retinoic acid on proliferation of estrogen-responsive transformed murine Leydig cells in serum-free culture.
Hirose T; Koga M; Kouhara H; Kishimoto S; Matsumoto K; Sato B
Cancer Res; 1990 Aug; 50(16):5060-4. PubMed ID: 2165854
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.
Koda M; Jarzabek K; Haczynski J; Knapp P; Sulkowski S; Wolczynski S
Oncol Rep; 2004 Sep; 12(3):517-21. PubMed ID: 15289830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
